Vaccine Acceptance and Effectiveness after Pandemic Era for Infectious Diseases Eradication

Dear Colleagues,

Vaccinations have gained relevance among the general population due to the spread of the SARS-CoV2 pandemic. Indeed, the availability of anti-SARS CoV2 vaccines have enabled the reduction of severe outcomes, though a massive resource implementation is required to achieve this. On the other hand, vaccination for vaccine preventable diseases other than SARS CoV2 have seen reduced use from healthcare services, providing an opportunity for an outbreak with potential pandemic power. In this scenario, people gained more knowledge of vaccine preventable disease based on two opposite approaches: acceptance of other vaccines or a refusal of other vaccines due to an increase in vaccine hesitancy. 

This Special Issue aims to collect manuscript that approach vaccine acceptance, including the management of adverse reaction, co-administration, communication, healthcare-related sources of information, and serological and cell-mediated immunity for different target populations. Contributors worldwide are encouraged to share their knowledge of vaccine acceptance from different healthcare perspectives, such as vaccine policy, management, administration, cost-effectiveness analysis and real-world data.

Prof. Dr. Alessandra Casuccio
Dr. Vincenzo Restivo
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.